Re: Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy: U. Michl, F. Molfenter, M. Graefen, P. Tennstedt, S. Ahyai, B. Beyer, L. Budäus, A. Haese, H. Heinzer, S. J. Oh, G. Salomon, T. Schlomm, T. Steuber, I. Thederan, H. Huland and D. Tilki J Urol 2015;193:479-483

J Urol. 2016 Mar;195(3):804; discussion 804-5. doi: 10.1016/j.juro.2015.08.103. Epub 2015 Nov 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Male
  • Neoplasm Recurrence, Local / chemically induced*
  • Phosphodiesterase 5 Inhibitors / adverse effects*
  • Prostatectomy*
  • Prostatic Neoplasms / chemically induced*
  • Prostatic Neoplasms / surgery*

Substances

  • Phosphodiesterase 5 Inhibitors